BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15999725)

  • 1. [Concept and epidemiology of diabetic nephropathy].
    Tomino Y; Tanimoto M
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():309-13. PubMed ID: 15999725
    [No Abstract]   [Full Text] [Related]  

  • 2. [Genetic factors with significance in pathogenesis of diabetic nephropathy--the role of polymorphism of renin-angiotensin system genes].
    Grzeszczak W
    Przegl Lek; 2000; 57 Suppl 3():19-24. PubMed ID: 11293230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene polymorphism of the renin-angiotensin system and progression of diabetic nephropathy.
    Orisio S
    J Nephrol; 1999; 12(1):9-17. PubMed ID: 10202997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic nephropathy: the ACE hypothesis.
    Marre M
    J Diabetes Complications; 1996; 10(3):126-8. PubMed ID: 8807455
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between angiotensin I converting enzyme gene polymorphism and diabetic nephropathy.
    Wu S; Xiang K; Weng Q; Lin X; Li Q; Dai Y; Zhao H; Shen W; Pu L; Li J
    Chin Med J (Engl); 1998 May; 111(5):478-9. PubMed ID: 10374364
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.
    Barnas U; Schmidt A; Illievich A; Kiener HP; Rabensteiner D; Kaider A; Prager R; Abrahamian H; Irsigler K; Mayer G
    Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting-enzyme gene and diabetic nephropathy in IDDM patients.
    Pfohl M; Frost D; Koch M; Clemens P; Patzies A; Schmülling RM; Beischer W; Häring HU
    Horm Metab Res; 1998 May; 30(5):276-80. PubMed ID: 9660089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians.
    Movva S; Alluri RV; Komandur S; Vattam K; Eppa K; Mukkavali KK; Mubigonda S; Saharia S; Shastry JC; Hasan Q
    J Diabetes Complications; 2007; 21(4):237-41. PubMed ID: 17616353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM.
    Vleming LJ; van der Pijl JW; Lemkes HH; Westendorp RG; Maassen JA; Daha MR; van Es LA; van Kooten C
    Clin Nephrol; 1999 Mar; 51(3):133-40. PubMed ID: 10099885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of ACE, ACE2 and AGTR1 genes for association with nephropathy in Type 1 diabetes mellitus.
    Currie D; McKnight AJ; Patterson CC; Sadlier DM; Maxwell AP;
    Diabet Med; 2010 Oct; 27(10):1188-94. PubMed ID: 20854388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S; Blohmé G; Sylvén C; Mulec H
    Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes.
    Schmidt S; Ritz E
    Nephrol Dial Transplant; 1997; 12 Suppl 2():37-41. PubMed ID: 9269698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
    Moleda P; Majkowska L; Safranow K; Adler G; Goracy I
    Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiotensin converting enzyme (ACE) gene polymorphism in a diabetic cohort and diabetic nephropathy].
    Levinson O; Oren S; Yagil C; Sapojnikov M; Wechsler A; Bloch R; Yagil Y
    Harefuah; 1999 May; 136(10):768-73, 843. PubMed ID: 10955109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy.
    Fujisawa T; Ikegami H; Kawaguchi Y; Hamada Y; Ueda H; Shintani M; Fukuda M; Ogihara T
    Diabetologia; 1998 Jan; 41(1):47-53. PubMed ID: 9498629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary factors in the development of diabetic renal disease.
    Marre M; Hadjadj S; Bouhanick B
    Diabetes Metab; 2000 Jul; 26 Suppl 4():30-6. PubMed ID: 10922971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the DD genotype and development of Japanese type 2 diabetic nephropathy.
    Gohda T; Makita Y; Shike T; Kobayashi M; Funabiki K; Haneda M; Kikkawa R; Watanabe T; Baba T; Yoshida H; Tomino Y
    Clin Nephrol; 2001 Dec; 56(6):475-80. PubMed ID: 11770799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
    Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
    Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic pattern in diabetic nephropathy.
    Tarnow L
    Nephrol Dial Transplant; 1996 Mar; 11(3):410-2. PubMed ID: 8671804
    [No Abstract]   [Full Text] [Related]  

  • 20. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.
    Marre M; Jeunemaitre X; Gallois Y; Rodier M; Chatellier G; Sert C; Dusselier L; Kahal Z; Chaillous L; Halimi S; Muller A; Sackmann H; Bauduceau B; Bled F; Passa P; Alhenc-Gelas F
    J Clin Invest; 1997 Apr; 99(7):1585-95. PubMed ID: 9120002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.